Skip to content

Perioperative Analgesia With Erector Spinae Plane Block in Liver Transplant Recipients

Optimization of Perioperative Analgesia With Erector Spinae Plane Block During Major Abdominal Surgeries in Patients With Impaired Liver Function

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06857331
Enrollment
50
Registered
2025-03-04
Start date
2024-05-05
Completion date
2025-12-10
Last updated
2025-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erector Spina Plan Block, Liver Transplant

Brief summary

The goal of this clinical trial is to learn if ESP block is safe and effective for perioperative analgesia in patients undergoing liver transplant. The main question it aims to answer are Is ESP block safe and has a minimum side effects, like hematoma? Is it effective for perioperative analgesia? Researchers will compare the results to a group of patients who underwent liver transplants without any regional anaesthesia techniques. Participants will receive bilateral thoracic ESP block on the day of the transplantation with a subsequent bilateral catheterization.

Interventions

Bilateral thoracic ESP block on the day of the transplantation with a subsequent catheterization will be suggested for the patients. In case of their written consent for the participation in the study this procedure will be performed on the day of the operation. 0.2% ropivacaine is going to be used throughout all the perioperative period.

Sponsors

Bogomolets National Medical University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* impaired liver function - cirrhosis or chronic liver disease with the development of hypocoagulation (APTT \> 35 sec, INR \> 1.5), thrombocytopenia, patients requiring major abdominal surgery, age \> 18 years, written consent to participate in the study was obtained

Exclusion criteria

* Platelet count \<50x109, failed ESP catheterization unilateral or bilateral, failed epidural anesthesia attempt, history of allergy or hypersensitivity to local anesthetics, hepatopulmonary syndrome, patients on mechanical ventilation before surgery, patients on CRRT before surgery, refusal to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Pain reduction postoperativefrom enrollment to the 2nd postoperative dayPain assessment with scores
Opioid reduction intraoperativelyfrom enrollment to the end of the operationThe amount of intraoperative fentanyl
Need for opioids postoperativelyfrom enrollment to the 2nd postoperative dayNeed for opioids postoperatively

Countries

Ukraine

Contacts

Primary ContactNazarii Mysynchuk
n.mysynchuk@oberig.ua+380731624586

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026